Recruiting NA Dental Caries

New treatment option for Dental Caries

Official title Clinical and Radiographic Assessment of First Permanent Molars With Cention-N

ClinicalTrials.gov ID: NCT07703176

What this study is testing

What it's testing
: Assessment of Clinical, Radiographic, and Oral Health-Related Quality of Life Following Restoration of First Permanent Molars with Cention N: A 12-Month Split-Mouth Randomized Controlled Trial Introduction Dental caries is one of the most common chronic diseases affecting children. First permanent molars (FPMs) are particularly susceptible to caries because of their early eruption and complex occlusal anatomy.
  • Time commitment: about 12 months
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 8 to 10

You may be able to join if

  • Clinical:
  • Children aged 8-10 years.
  • Children classified as ASA physical status I or II.
  • Children demonstrate positive or definitely positive behavior (scores 3 or 4 on the Frankl Behavior Rating Scale).
  • Children who are available for regular recall visits throughout the study period.

You likely can't join if

  • Clinical:
  • Children with behavioral difficulties or without signed parental consent.
  • Children are classified as ASA physical status class III or higher.
  • Teeth presenting clinical signs of pulpitis or necrosis (e.g., nocturnal pain, fistula, abscess, pulp exposure, or pathological mobility)...
  • Evidence of abnormal radiolucency involving the pulp chamber or root apex.
  • Detection of furcal bone radiolucency or abnormal root resorption.
See the full eligibility criteria
Who can join
  • Clinical:
  • Children aged 8-10 years.
  • Children classified as ASA physical status I or II.
  • Children demonstrate positive or definitely positive behavior (scores 3 or 4 on the Frankl Behavior Rating Scale).
  • Children who are available for regular recall visits throughout the study period.
  • Presence of bilateral carious lesions in permanent first molars, with a clear description of lesion depth whenever possible.
  • Asymptomatic vital permanent first molars showing no clinical or radiographic signs of pathology. Radiographic:
  • Normal lamina dura and periodontal ligament space.
  • No apical radiolucency.
What rules you out
  • Clinical:
  • Children with behavioral difficulties or without signed parental consent.
  • Children are classified as ASA physical status class III or higher.
  • Teeth presenting clinical signs of pulpitis or necrosis (e.g., nocturnal pain, fistula, abscess, pulp exposure, or pathological mobility). Radiographic:
  • Evidence of abnormal radiolucency involving the pulp chamber or root apex.
  • Detection of furcal bone radiolucency or abnormal root resorption.

The study team makes the final eligibility decision.

Where it's taking place

  • Minya, Asyut Governorate, Egypt

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The study runs about 12 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.

Who can join this trial?

This study is enrolling all sexes, 8 years to 10 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Minya, Asyut Governorate, Egypt. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.